Literature DB >> 15122721

Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.

Luanne M Metz, Yunyan Zhang, Michael Yeung, David G Patry, Robert B Bell, Cristina A Stoian, V Wee Yong, Scott B Patten, Pierre Duquette, Jack P Antel, J Ross Mitchell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15122721     DOI: 10.1002/ana.20111

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  47 in total

Review 1.  Modulating processes within the central nervous system is central to therapeutic control of multiple sclerosis.

Authors:  Tjalf Ziemssen
Journal:  J Neurol       Date:  2005-11       Impact factor: 4.849

Review 2.  Combination therapies in multiple sclerosis.

Authors:  Ralf Gold
Journal:  J Neurol       Date:  2008-03       Impact factor: 4.849

Review 3.  Novel oral agents for multiple sclerosis.

Authors:  Jodie M Burton; Paul O'Connor
Journal:  Curr Neurol Neurosci Rep       Date:  2007-05       Impact factor: 5.081

Review 4.  Neuroprotection and neuroregeneration in multiple sclerosis.

Authors:  Martin Stangel
Journal:  J Neurol       Date:  2008-12       Impact factor: 4.849

5.  Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders.

Authors:  Carlo Contini; Silva Seraceni; Rosario Cultrera; Massimiliano Castellazzi; Enrico Granieri; Enrico Fainardi
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-02-21

6.  Translation attenuation by minocycline enhances longevity and proteostasis in old post-stress-responsive organisms.

Authors:  Gregory M Solis; Rozina Kardakaris; Elizabeth R Valentine; Liron Bar-Peled; Alice L Chen; Megan M Blewett; Mark A McCormick; James R Williamson; Brian Kennedy; Benjamin F Cravatt; Michael Petrascheck
Journal:  Elife       Date:  2018-11-27       Impact factor: 8.140

Review 7.  Microglia and inflammation: conspiracy, controversy or control?

Authors:  Adelaide Fernandes; Leonor Miller-Fleming; Teresa F Pais
Journal:  Cell Mol Life Sci       Date:  2014-07-10       Impact factor: 9.261

8.  Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha).

Authors:  Stefan M Gold; Manda V Sasidhar; Laurie B Morales; Sienmi Du; Nancy L Sicotte; Seema K Tiwari-Woodruff; Rhonda R Voskuhl
Journal:  Lab Invest       Date:  2009-08-10       Impact factor: 5.662

Review 9.  Minocycline: far beyond an antibiotic.

Authors:  N Garrido-Mesa; A Zarzuelo; J Gálvez
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

10.  Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke.

Authors:  Noriyuki Matsukawa; Takao Yasuhara; Koichi Hara; Lin Xu; Mina Maki; Guolong Yu; Yuji Kaneko; Kosei Ojika; David C Hess; Cesar V Borlongan
Journal:  BMC Neurosci       Date:  2009-10-06       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.